News

A Salk Institute-led team has generated a map of the human methylome, gaining insight into patterns of DNA methylation of various tissues.

Centre for Genomic Regulation (CRG) scientists have undertaken to map the neural circuitry involved in the conversion of olfactory inputs into navigational behaviors (chemotaxis) in the fruit fly Drosophila larvae.

Companies to collaborate on standardizing and de-risking cell thawing process for a Phase 2 cell therapy for the treatment of diabetic foot ulcers.

To curb further spread of Ebola in Sierra Leone, a team of scientists that is part of an international, multi-organizational effort has released their first dataset of the virus’ genetic structure online.

As the 100,000 Genomes Project moves into Phase 3 Congenica has been named as a platform provider.

This agreement combines ubiquitin focused biology expertise with proprietary chemistry platform to identify small molecule libraries that target the ubiquitin system.

Researchers have developed a rapid, scalable, and cost-effective method for chromosomal phasing that provides researchers with a new method to determine if genetic variants are linked on the same chromosome.

This partnership sets out to develop cell-free DNA (cfDNA) reference standards.

Researchers have discovered for the first time that a metabolite of an FDA-approved drug for metastatic prostate cancer, has more anti-cancer properties than its precursor.

Albany Molecular Research Inc. has announced that it has signed a collaborative agreement with biotechnology company HarkerBIO LLC to co-market their structure-based drug discovery services.